The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lawrence, C. E.
Right arrow Articles by Kennedy, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawrence, C. E.
Right arrow Articles by Kennedy, M. W.
The Journal of Immunology, 2000, 164: 4229-4234.
Copyright © 2000 by The American Association of Immunologists

Nitric Oxide Mediates Intestinal Pathology But Not Immune Expulsion During Trichinella spiralis Infection in Mice1

Catherine E. Lawrence2,*, Jacqueline C. M. Paterson*, Xiao-Qing Wei{dagger}, Foo Y. Liew{dagger}, Paul Garside{dagger} and Malcolm W. Kennedy*

* Division of Infection and Immunity, Institute of Biomedical and Life Sciences, and {dagger} Department of Immunology and Bacteriology, University of Glasgow, Glasgow, United Kingdom


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The relationship between intestinal pathology and immune expulsion of gastrointestinal (GI) nematodes remains controversial. Although immune expulsion of GI helminth parasites is usually associated with Th2 responses, the effector mechanisms directly responsible for parasite loss have not been identified. We have previously shown that while the intestinal pathology accompanying the expulsion of the GI parasite Trichinella spiralis may be dependent on IL-4 and mediated by TNF, parasite loss is independent of TNF. In contrast, intestinal pathology in other disease models has been attributed to Th1 cytokines, although it closely resembles that seen in helminth infections. Whereas production of inducible NO synthase (iNOS) in the gut is important for both homeostasis of the epithelial layer and in protection against pathogenic microorganisms, overproduction of NO has been implicated in the pathogenesis of a number of inflammatory conditions. We therefore investigated the role of NO in T. spiralis infection using iNOS-deficient mice. iNOS-/- and iNOS-/+ mice were infected with T. spiralis, and parasite expulsion and intestinal pathology were followed. Parasite expulsion proceeded similarly in both groups of animals, but significant intestinal pathology was only observed in the heterozygous mice. Thus it appears that, although the protective effects of Th2 responses in GI helminth infection do not require NO, this mediator contributes substantially to the associated enteropathy. NO may therefore be an important mediator of enteropathy in both Th1- and Th2-inducing conditions.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Immune expulsion of nematodes parasitizing the small intestine is often accompanied by a severe T cell-mediated enteropathy, and treatments that suppress this pathology may abrogate the loss of the parasites (1, 2, 3). This therefore presents an obstacle to vaccination against such parasites because it might be necessary to induce pathology to be effective. However, we recently demonstrated that TNF-receptor 1-defective mice are able to immunologically expel the highly pathogenic Trichinella spiralis without significant pathology, thereby demonstrating that while pathology accompanies the protective mechanism, it is not required for it (4). This opens up the possibility that immunological interventions could be designed to avoid the induction of pathology. However, interference with cytokine signaling in the intestine as part of an immunization strategy may be difficult or undesirable given its role in other essential processes. To target effective therapy or immunization strategies it will therefore be necessary to extend our understanding of the mediators directly involved in immune expulsion and pathology.

Reactive nitrogen intermediates including NO have been identified as important effector molecules that can restrict pathogen growth in infected hosts while also playing a role in immunoregulation and pathology (5, 6, 7, 8, 9, 10, 11, 12, 13). Expression of inducible NO synthase (iNOS,3 NOS2) is elicited in a wide variety of cell types by pro-inflammatory cytokines or bacterial products such as LPS, and results in high level production of NO from L-arginine substrate (5, 6, 7, 8). A number of studies have indicated that NO produced by cytokine-activated macrophages is important in immune responses against bacterial, fungal, helminth, and protozoan infectious agents (9, 10, 11, 12, 13). Furthermore, the immunomodulatory activity of NO is manifested in potent immunosuppression and in influencing Th cell development (5, 6, 14, 15). Production of excessive amounts of NO, however, has been implicated in a number of pathological conditions, appearing to play a crucial role in diabetes mellitus, graft-vs-host disease, rheumatoid arthritis, and inflammatory bowel disease (IBD) (5, 16, 17, 18, 19). Intestinal pathology in a number of immunologically mediated enteropathies such as graft-vs-host disease, IBD, and the spontaneous gut lesions that develop in certain cytokine knock out mice is usually associated with Th1 type responses and TNF-{alpha} (19, 20, 21, 22), and iNOS induced by inflammatory cytokines is thought to play an important role in these situations. However, it has recently been demonstrated that other models of IBD could also be associated with Th2 responses (23, 24, 25).

Many studies have analyzed the protective role of NO during Th1-inducing infections, but few have analyzed the effects of this mediator in the context of a Th2-stimulating infection such as with helminth parasites. Although the gross enteropathy associated with the immune expulsion of intestinal helminths mirrors that associated with many Th1 responses, both the pathology and parasite loss are Th2-dependent phenomena. Indeed, we have recently shown that expulsion proceeds in the absence of pathology in mice defective for the TNF signaling system, demonstrating that pro-inflammatory cytokines appear to be under the control of Th2 responses in this case, and that pathology is not obligatory for parasite loss (4). These findings have implications for vaccine development and the control of idiopathic IBDs, yet the downstream/direct mediators of enteropathy in Th2-mediated events such as in helminth infections remain to be identified.

In this paper we provide evidence that NO is an important mediator of enteropathy in infection with the intestinal nematode T. spiralis, and propose that iNOS production is under the control of TNF in such circumstances. Our findings reinforce the concept that enteropathy is not required for the removal of nematode parasites. Furthermore, the identification of NO as a crucial mediator provides a more amenable target for intervention than manipulation of cytokines in the control of enteropathy in infections or idiopathic conditions. If NO is indeed the end point mediator of enteropathy, regardless of aetiology, then the new generation of inhibitors and scavengers of NO will be useful therapeutic agents (26).


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals and infection

The maintenance, infection, and recovery of T. spiralis were essentially as described previously (4). Mice were infected with 400 T. spiralis larvae on day 0 and killed at various times postinfection (p.i.) as detailed. C57BL/6 mice purchased from Harlan-Olac (Oxford, U.K.) were maintained under standard laboratory conditions. MF-1 x 129 mice with a homozygous disruption of the iNOS gene (iNOS-/-) and heterozygous littermates (iNOS-/+) were bred and maintained in the Joint Animal Facility, University of Glasgow. The homozygous and heterozygous mice thus generated were backcrossed with MF-1 mice for three generations. Heterozygous mice have previously been shown to be phenotypically identical to wild-type MF-1 mice (13, 27).

Quantitation of intestinal pathology

After weighing the entire small intestine, mucosal architecture, and epithelial cell mitotic activity were assessed in samples of jejunum taken 10 cm from the pylorus, as described previously (4). Samples were fixed in 25% acetic acid/75% ethanol and stained with Schiff reagent (Sigma, Poole, U.K.). Specimens were microdissected and villus and crypt lengths measured using an eyepiece micrometer. The number of mitotic figures per crypt were also counted. Ten villi and crypts were measured for each sample. Consecutive samples of jejunum were fixed in Carnoy’s fixative and processed using standard histological techniques. Sections were stained with 0.5% toluidine blue (pH 0.3) for visualization of mast cells. The numbers of mucosal mast cells were counted per 25 villus crypt units (VCU) and data expressed per VCU.

Lymphocyte culture and cytokine responses

Single cell suspensions of mesenteric lymph nodes (MLN) were prepared and incubated in the presence of T. spiralis larval homogenate (50 µg/ml protein). Culture supernatants were harvested after 24 h, and IL-2, IL-4, IL-5, and IFN-{gamma} levels measured by ELISA using paired Abs as described previously (4). TNF-{alpha} levels were determined in serum by ELISA according to the manufacturer’s instructions (PharMingen, Oxford, U.K.).

Measurement of Ab responses

Parasite-specific IgG1 and IgG2a and total IgE levels were determined as described previously (4). T. spiralis larval homogenate was used as a target Ag at 10 µg/ml in ELISA, and sera were diluted 1/100. IgG1 and IgG2a were detected using biotinylated anti-mouse IgG1 or IgG2a (PharMingen) at 2 µg/ml each, followed by streptavidin-peroxidase (SAPU, Carluke, U.K.). Total serum IgE levels were measured by ELISA, anti-mouse IgE was used as capture Ab, and IgE was detected using biotinylated anti-mouse IgE (PharMingen). An IgE mAb specific for TNP (PharMingen) was used as standard.

Measurement of NO

Total nitrate and nitrite concentrations in sera were estimated by the conversion of nitrate into nitrite. Total nitrite content was then measured by the Greiss reaction using NaNO2 as standard with detection limit of 1 µM (28). Briefly, 30 µl of each sample was incubated for 1 h at 37°C with 5 µl Aspergillus nitrate reductase (5 U/ml; Sigma) and 15 µl of NADPH (1.25 mg/ml; Sigma). After incubation, 100 µl of Greiss reagent (1% sulfanilamide/0.1% naphthylethylene diamine dihydrochloride/2.5% H3PO4) and 100 µl trichloroacetic acid (10% aqueous solution) were added and incubated at room temperature for 10 min. Protein precipitates were removed by centrifugation at 13,000 x g for 5 min. Supernatants (100 µl) were transferred in duplicate to a 96-well flat-bottom plate. Absorbance at 570 nm was measured, and NO concentrations were estimated against a sodium nitrate standard curve.

Statistics

Results are expressed as means ± 1 SEM. Statistical differences (p = 0.05) between experimental groups were determined using the Mann-Whitney U test.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Our previous work demonstrated that while IL-4 was an absolute requirement for both parasite expulsion and pathology during infection with T. spiralis, TNF was only required for expression of the pathological but not the protective responses (4). One possible mechanism by which TNF may exert this effect is through the production of NO via iNOS induction.

NO in T. spiralis infection

To investigate whether NO was produced during infection of mice with T. spiralis, C57BL/6 mice were infected with 400 muscle larvae, and concentrations of nitrite and nitrate were measured in the serum. Production of NO by T. spiralis infected C57BL/6 mice was significantly increased; levels rose from 11.2 ± 1.6 µM to 23.2 ± 1.9 µM (p < 0.05). This confirmed studies of T. spiralis infection in rats (29). We next investigated the role of NO in protection and pathology using iNOS-deficient mice.

T. spiralis-associated pathology is diminished in iNOS-deficient mice despite normal expulsion of the parasite

The kinetics of parasite expulsion from heterozygous (iNOS-/+) or homozygous (iNOS-/-) mice infected with T. spiralis were identical to those seen in wild-type mice (Fig. 1Go). There was no significant difference in the establishment (day 6 p.i.) or the expulsion (day 13 p.i.) of the parasite from iNOS-/- mice. To determine whether expulsion may have occurred earlier in iNOS-/- mice, animals were also examined at day 10 p.i., but again there was no significant difference between the two groups at this time (data not shown).



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 1. Parasite burdens in iNOS-deficient mice infected with T. spiralis. Mice were infected with 400 T. spiralis muscle larvae and worm burdens assessed on day 6 and day 13 p.i. Adult worm burdens are represented as mean ± SEM. *, Significant difference between day 6 and day 13 p.i. (p < 0.05). This figure is representative of two experiments.

 
Although there was no significant difference in intestinal architecture between naive iNOS-/+ or iNOS-/- animals, only the heterozygous mice displayed severe enteropathy when infected with T. spiralis, comprising villus atrophy and crypt hyperplasia with a concomitant increase in the number of mitotic figures per crypt (Fig. 2Go). iNOS-deficient mice showed no evidence of villus atrophy, and the crypt hyperplasia observed was significantly less pronounced than that seen in the heterozygous mice. The number of mitotic figures per crypt were also significantly lower in the iNOS-deficient mice compared with the heterozygotes, again indicating reduced crypt hyperplasia. This pattern of reduced enteropathy in iNOS-/- mice is similar to that previously seen in TNF-R1-deficient animals infected with T. spiralis (4).



View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 2. Development of intestinal pathology in iNOS-deficient mice infected with T. spiralis. Crypt lengths, villus lengths, and number of mitotic figures/crypt were measured at days 6 and 13 p.i. Uninfected mice are represented at day 0. Results are shown as mean ± SEM. A, iNOS-/+ crypt and villus lengths (n = 6). B, iNOS-/- crypt and villus lengths (n = 7). C, Number of mitotic figures/crypt. *, Significant difference between infected and uninfected animals (p < 0.05); {dagger}, significant difference between iNOS-/+ and iNOS-/- (p < 0.05). This figure is representative of two experiments.

 
Th2-associated cytokine expression is decreased in iNOS-deficient mice

To investigate the role of T helper subsets during infection of iNOS-deficient mice with T. spiralis, we determined levels of IL-2, IFN-{gamma}, IL-4, IL-5, and TNF-{alpha} produced by these animals (Table IGo). There was a significant increase in Th2 cytokines in iNOS-/+ mice during infection but little increase in IFN-{gamma}. In contrast, iNOS-/- mice showed increased production of both IL-2 and IFN-{gamma} with little or no change in the levels of IL-4 or IL-5 following infection. Importantly, while serum TNF-{alpha} levels in iNOS-/- mice did not increase, those in iNOS-/- mice were significantly elevated.


View this table:
[in this window]
[in a new window]
  		Table I. Cytokine profiles by MLN cells following in vitro Ag stimulation during infection with T. spiralis1

 
It has been known for some time that NO has an anti-proliferative effect on both T and B cells (30, 31), and therefore the proliferative responses of cells from MLN to T. spiralis Ag following infection were determined (Fig. 3Go). Although MLN cells from both strains of mice proliferated in response to Ag, those from iNOS-deficient infected mice proliferated to a significantly greater extent than those from heterozygous mice.



View larger version (13K):
[in this window]
[in a new window]
  		FIGURE 3. Ag-specific cell proliferation in iNOS-deficient mice infected with T. spiralis. MLN cells were harvested from uninfected or infected iNOS-/+ and iNOS-/- mice 13 days p.i. and stimulated with 50 µg/ml Trichinella muscle Ag. Results are shown as mean ± SEM. *, Significant difference between infected and uninfected animals (p < 0.05); {dagger}, significant difference between iNOS-/+ and iNOS-/- (p < 0.05). This figure is representative of two experiments.

 
Th2-associated humoral response is decreased in iNOS-deficient mice

Isotype-specific anti-Trichinella Ag Abs were also measured as an indicator of Th activity. High IgG1 and IgE levels and low IgG2a levels were observed in heterozygous mice (Table IIGo). Although levels of IgG1 and IgE produced by iNOS-deficient mice were still significantly elevated with respect to control animals, they were significantly less than those observed in infected heterozygous animals. Conversely, while levels of IgG2a did not increase significantly in infected heterozygous mice, they were significantly elevated in the iNOS-deficient animals.


View this table:
[in this window]
[in a new window]
  		Table II. Ab responses during infection with T. spiralis1

 
Mastocytosis is decreased in iNOS-deficient mice

Numerous studies have indicated that mast cells play an important role in the expulsion of T. spiralis, and they have also been implicated in the mediation of intestinal pathology in other disease models, and NO has been demonstrated to play a role in the activation of mast cells (32, 33, 34). Although a mucosal mastocytosis was apparent in iNOS-deficient mice infected with T. spiralis, it was substantially lower than that observed in the heterozygous animals (Fig. 4Go).



View larger version (11K):
[in this window]
[in a new window]
  		FIGURE 4. Intestinal mast cell numbers in jejunum of iNOS-deficient mice infected with T. spiralis. Samples were collected from uninfected and infected iNOS-/+ and iNOS-/- mice 13 days p.i. Results are shown as mean ± SEM. *, Significant difference between infected and uninfected animals (p < 0.05); {dagger}, significant difference between iNOS-/+ and iNOS-/- (p < 0.05). This figure is representative of two experiments.

 
Fluid accumulation is decreased in the intestine of iNOS-deficient mice

It has been suggested that a change in intestinal fluid dynamics that favors fluid accumulation in the gut lumen and an increase in the small intestine smooth muscle contractility results in the expulsion of loosely attached parasites (35). Additionally, NO is involved in the induction of vascular leak syndromes that lead to fluid accumulation in intestinal tissues (36). Although there was a significant increase in the wet weight of the small intestine in both groups of animals, the weights of the intestines from iNOS-/- mice were significantly lower than those from iNOS-/+ mice (Fig. 5Go). Fluid accumulation in the gut lumen of infected mice, mediated by NO, is therefore unlikely to play a role in the expulsion of T. spiralis.



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 5. Wet weight of the entire small intestine of iNOS-deficient mice infected with T. spiralis. The entire small intestine from uninfected and infected iNOS-/+ and iNOS-/- was weighed 13 days p.i. Results are shown as mean ± SEM. *, Significant difference between infected and uninfected animals (p < 0.05); {dagger}, significant difference between iNOS-/+ and iNOS-/- (p < 0.05). This figure is representative of two experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The results of this study have two major implications. First, NO is a central mediator of pathology in the context of a Th2-mediated protective immune response. Second, pathology is not required for removal of the parasite. This reinforces our previous findings in animals defective for TNF signaling, but the identification of NO as a downstream mediator allows the development of interventions in certain infections and immunopathologies without potentially deleterious manipulations of the cytokine system.

It has been well documented that protection against Th1-inducing infections is associated with the production of NO via iNOS up-regulation, and NO has also been implicated in many Th1-mediated enteropathies (10, 11, 12, 13, 14, 17, 18, 19). However, the pathology observed during infection with the highly pathogenic gastrointestinal (GI) parasite T. spiralis is mediated by a Th2 response (4). At present, little work has been conducted on the role of NO in Th2-inducing infections, so we aimed to establish the role of iNOS in the induction of protection and pathology in a Th2-polarizing infection. The observations were consistent with our previous studies in showing that intestinal pathology is not required for the expulsion of GI nematode parasites. Moreover, while NO does not appear to be important in protection against helminths, it is crucial for the pathology induced. Recent studies have also suggested that NO plays a dual role in inducing protective and pathological responses in other systems. Inhibition of iNOS during a number of infections, including viruses, bacteria, and protozoan parasites, could greatly improve survival despite an increase in pathogen numbers. (37, 38, 39). Importantly, NO may now be considered as an end point mediator of pathology induced by either Th1 or Th2 polarized responses.

Like earlier studies in rats infected with T. spiralis (30), we show an increase NO levels in the serum of T. spiralis-infected mice. Although NO appears to be directly toxic to some helminths in vitro (40, 41, 42), our study now shows that NO synthesized by iNOS is not essential for the expulsion of T. spiralis from mice. The results presented here also demonstrate that iNOS plays a crucial role in the induction of the Th2-mediated enteropathy that accompanies GI nematode infections. This contrasts with some models of IBD where NO is associated with excessive production of Th1 cytokines, and where the use of NO inhibitors and iNOS-deficient mice have clearly demonstrated a central role for NO in the induction of enteropathy (17, 18, 19). Interestingly, it has recently been shown that Th2-type responses may also mediate intestinal inflammation in other models of enteropathy, although the role of NO in these pathologies is unknown (23, 24, 25).

The source of NO in enteropathy has not been identified but a number of cells including epithelial cells, macrophages, and mast cells have been implicated (9, 43, 44, 45). Epithelial cells are the first point of host contact for invasive intestinal pathogens and may initiate mucosal inflammatory responses via production of pro-inflammatory cytokines and mediators including NO (8, 43). T. spiralis occupies an intramulticellular niche in small intestinal epithelium and infected epithelial cells have been shown to respond by synthesizing cytokines (46). It is therefore possible that the perturbation of the epithelium by invasion of T. spiralis results in the development of an aberrant mucosal immune response mediated by iNOS and the subsequent compromise of intestinal integrity.

A cardinal role for mast cells in host protection against certain GI nematode infections (T. spiralis in particular) has been shown in numerous studies (47, 48). Mast cells have also been shown to induce intestinal pathology by a number of mechanisms including the release of mediators such as cytokines, histamine, and NO (32, 33, 34, 49). There is also evidence that mast cells have the ability to synthesize and release NO derivatives through their own expression of iNOS induced by IgE immune complexes (44). Furthermore, iNOS has been shown to be crucial in allergic inflammatory processes by regulating the activation and degranulation of mast cells (50). However, it has also been suggested that mast cells normally serve to inhibit increased mucosal permeability induced by iNOS activity in the gut (33, 34). We find that mast cell numbers were decreased in T. spiralis-infected iNOS-deficient mice, so even if they are involved in parasite expulsion in this context, then they do so without the concomitant pathology.

NO may also exert its effects in enteropathy and parasite infection through its immunomodulatory role in Th cell polarization. It was observed that although iNOS-deficient mice infected with T. spiralis exhibited a decreased Th2 response compared with heterozygous mice, this was nevertheless sufficient to induce expulsion of the parasite. Similarly, iNOS-deficient mice infected with Leishmania major, Schistosoma mansoni, or Staphylococcus aureus have been demonstrated to have enhanced Th1 responses compared with wild-type mice (7, 13, 51). The mechanism by which NO influences immunoregulation is unknown at present but it has been suggested that NO could preferentially regulate the production of Th1/Th2 cytokines through modification of gene transcription, through the induction of apoptosis in Th1 cells, and/or by down-regulating selectin-dependent Th1 cell accumulation at sites of inflammation (14, 15, 30, 52, 53).

The production of TNF-{alpha} in T. spiralis-infected iNOS-deficient mice was decreased in comparison to heterozygous mice. In contrast, it has been shown that iNOS-deficient mice infected with S. aureus had increased production of TNF-{alpha} compared with heterozygotes, and it was concluded that the increased levels of TNF-{alpha} were the result of the exaggerated Th1 polarization induced in these animals (7). However, NO has also been shown to enhance the induction of TNF-{alpha} synthesis both in vivo and in vitro (15). The reduced levels of TNF-{alpha} in iNOS-deficient mice infected with T. spiralis may instead be due to its induction by a Th2 response rather than a Th1 response. More recently, expulsion of Trichuris muris from TNF-R gene-deficient mice was prevented, and it was proposed that TNF-{alpha} mediated its protective effects by regulating the Th2 cytokine response in the intestine (54).

Other NO-dependent functions (including alterations in vasodilation, endothelial integrity, vascular adhesion, emigration of inflammatory cells, increased mucin secretion by goblet cells, altered intestinal smooth muscle function, and intestinal fluid secretion) may also play a role in the enteropathy accompanying parasite expulsion (29, 50, 53, 55, 56, 57). It has been suggested that a change in intestinal smooth muscle and fluid dynamics, which favors increased propulsion and fluid accumulation in the gut lumen, leads to the expulsion of loosely attached parasites (35). However, fluid accumulation in the gut lumen of infected mice is unlikely to play a role in the expulsion of T. spiralis because the wet weights of the small intestines from iNOS-deficient mice were significantly lower than those of heterozygous mice. Furthermore, these parasites are embedded in the intestinal epithelium and so would be less susceptible to peristaltic removal.

It is possible that the villus atrophy observed in T. spiralis infection, similar to that described following administration of IL-12, IFN-{gamma}, or TNF-{alpha} (56), may be induced by NO either through direct cellular injury via peroxynitrite or indirectly via apoptosis of villus epithelial cells. Although villus atrophy was ablated in iNOS-deficient mice, crypt hyperplasia was also reduced, suggesting that NO is playing a greater role in inducing intestinal inflammation than merely causing the death of epithelial cells. Thus, iNOS may induce intestinal pathology in T. spiralis infection in a number of ways which could include induction of inflammatory cytokines such as TNF, activation of mast cells, immunomodulation, alterations in intestinal physiology, or by the induction of apoptosis of villus epithelial cells.

In conclusion, we have demonstrated that NO is an important component of the pathological response accompanying the expulsion of a GI nematode parasite. In the absence of high output NO synthesis, mice did not develop the severe enteropathy which usually accompanies infection with T. spiralis, but this did not inhibit the ability of the animals to expel the parasite. Thus, iNOS may promote parasite expulsion by down-regulating the induction of Th1 responses, thereby promoting a Th2 response. However, limitation of excessive NO production and the resulting tissue damage is no doubt of general benefit to the host. These results provide insights into the interplay of the protective and pathological responses associated with the expulsion of GI parasites. Importantly, they further suggest that Th2 responses can induce NO-mediated pathology. Hence, selective inhibitors of iNOS, currently under consideration for the treatment of IBDs, may prove beneficial for both Th1 and Th2-mediated enteropathies without compromising Th2 protective responses (26). It is now important to establish the exact mechanism by which iNOS is induced and exerts its pathological influence in intestinal inflammation.


   Footnotes
 
1 This work was supported by Wellcome Trust Grants 042679 (to M.W.K.) and 055503 (to C.E.L.). P.G. is supported by a Wellcome Trust Career Development Fellowship. Back

2 Address correspondence and reprint requests to Dr. Catherine E. Lawrence, Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black Building, University of Glasgow, Glasgow, G12 8QQ, U.K. Back

3 Abbreviations used in this paper: iNOS, inducible NO synthase; GI, gastrointestinal; IBD, inflammatory bowel disease; MLN, mesenteric lymph node; p.i., postinfection. Back

Received for publication November 8, 1999. Accepted for publication February 8, 2000.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Manson-Smith, D. F., R. G. Bruce, D. M. V. Parrott. 1979. Villous atrophy and expulsion of intestinal Trichinella spiralis are mediated by T cells. Cell. Immunol. 47:285.[Medline]
  2. Garside, P., R. K. Grencis, A. McI. Mowat. 1992. T lymphocyte dependent enteropathy in murine Trichinella spiralis infection. Parasite Immunol. 14:217.[Medline]
  3. Ruitenberg, E. J., F. Leenstrsa, A. Elgersma. 1977. Thymus dependence and independence of intestinal pathology in a Trichinella spiralis infection: a study in congenitally athymic (nude) mice. Br. J. Exp. Pathol. 58:311.[Medline]
  4. Lawrence, C. E., J. C. M. Paterson, L. M. Higgins, T. T. MacDonald, M. W. Kennedy, P. Garside. 1998. IL-4-regulated enteropathy in an intestinal nematode infection. Eur. J. Immunol. 28:2672.[Medline]
  5. Moilanen, E., H. Vapaatala. 1995. Nitric oxide in inflammation and immune response. Ann. Med. 27:359.[Medline]
  6. Nathan, C., Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls and controls. Cell 78:915.[Medline]
  7. McInnes, I. B., B. Leung, X.-Q. Wei, C. G. Gemmel, F. Y. Liew. 1998. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J. Immunol. 160:308.[Abstract/Free Full Text]
  8. Witthöft, T., L. Eckmann, J. M. Kim, M. F. Kagnoff. 1998. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am. J. Physiol. 275:G564.[Abstract/Free Full Text]
  9. Denis, M.. 1991. Interferon-{gamma}-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150.[Medline]
  10. James, S., J. Glaven. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208.[Abstract]
  11. Adams, L., J. J. Hibbs, R. Taintor, L. Krahenbuhl. 1990. Microbiostatic effect of murine activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725.[Abstract]
  12. Liew, F. Y., S. Millott, C. Parkinson, R. Palmer, S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794.[Abstract]
  13. Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P. Huang, D. Xu, W. Muller, S. Moncada, F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.[Medline]
  14. Niedbala, W., X.-Q. Wei, D. Piedrafita, D. Xu, F. Y. Liew. 1999. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur. J. Immunol. 29:2498.[Medline]
  15. Huang, F.-P., W. Niedbala, X.-Q. Wei, D. Xu, G.-J. Feng, J. H. Robinson, C. Lam, F. Y. Liew. 1998. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 28:4062.[Medline]
  16. Kolb, H., V. Kolb-Bachofen. 1992. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol. Today 13:157.[Medline]
  17. Zingarelli. B., C., C. Szabo, A. L. Salzman. 1999. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 45:199.[Abstract/Free Full Text]
  18. Rachmilewitz, D., F. Karmeli, E. Okon, M. Bursztyn. 1995. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37:247.[Abstract/Free Full Text]
  19. Garside, P., A. K. Hutton, A. Severn, F. Y. Liew, A. McI. Mowat. 1992. Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur. J. Immunol. 22:2141.[Medline]
  20. Kramer, S., A. Schimpl, T. Hunig. 1995. Immunopathology of interleukin (IL)-2-deficient mice: thymus dependence and suppression of thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182:1769.[Abstract/Free Full Text]
  21. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:203.[Medline]
  22. Garside, P., C. Bunce, R. C. Tomlinson, B. L. Nichols, A. McI. Mowat. 1993. Analysis of enteropathy induced by tumor necrosis factor-{alpha}. Cytokine 5:24.[Medline]
  23. Mizoguchi, A., E. Mizoguchi, and A. K. Bhan, A.K. 1999. The critical role of interleukin 4 but not interferon {gamma} in the pathogenesis of colitis in T-cell receptor a mutant mice. Gasteroenterology 116:320.
  24. Iijima, H., I. Takahashi, D. Kishi, J-K. Ki, S. Kawano, M. Hori, H. Kiyono. 1999. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor {alpha} chain-deficient mice. J. Exp. Med. 190:607.[Abstract/Free Full Text]
  25. Boirivant, M., I. J. Fuss, A. Chu, W. Strober. 1998. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188:1929.[Abstract/Free Full Text]
  26. Muscara, M. N., J. L. Wallace. 1999. Nitric oxide. V. Therapeutic potential of nitric oxide donors and inhibitors. Am. J. Physiol. 76:G1313.
  27. Rai, R. M., F. Y. J. Lee, A. Rosen, Q. Y. Shi, Z. L. Hui, A. Koteish, F. Y. Liew, C. Zaragoza, C. Lowenstein, A. M. Diehl. 1998. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. USA 95:13829.[Abstract/Free Full Text]
  28. Sternberg, J. M., M. A. Mabbott, Sutherland I. A., F. Y. Liew. 1994. Inhibition of nitric oxide synthesis leads to reduced parasitaemia in murine Trypanosoma brucei infection. Infect. Immun. 62:2135.[Abstract/Free Full Text]
  29. Hogaboam, C. M., S. M. Collins, M. G. Blennerhassett. 1996. Effects of oral L-NAME during Trichinella spiralis infection in rats. Am. J. Physiol. 34:G338.
  30. Albina, J. E., J. A. Abate, W. L. Henry. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-{gamma} in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144.[Abstract]
  31. Falzarrano, G., W. Krenger, K. M. Snyder, J. Delmonte, M. Karandikar, J. L. Ferrara. 1996. Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-{alpha} in mice with acute graft-versus-host disease. Blood 87:2853.[Abstract/Free Full Text]
  32. Crowe, S. E., M. H. Perdue. 1992. Functional abnormalities in the intestine associated with mucosal mast cell activation. Reg. Immunol. 4:113.[Medline]
  33. Kanwar, S., J. L. Wallace, D. Befus, P. Kubes. 1994. Nitric oxide inhibition increases epithelial permeability via mast cells. Am. J. Physiol. 266:G222.[Abstract/Free Full Text]
  34. Komatsu, S., M. B. Grisham, J. M. Russell, D. N. Granger. 1997. Enhanced mucosal permeability and nitric oxide synthase activity in jejunum of mast cell deficient mice. Gut 41:636.[Abstract/Free Full Text]
  35. Vallance, B.A., K. Croitoru, S. M. Collins. 1998. T-lymphocyte-dependent and -independent intestinal smooth muscle dysfunction in the T. spiralis infected mouse. Am. J. Physiol. 275:G1157.[Abstract/Free Full Text]
  36. Boughton-Smith, N. K., S. M. Evans, F. Laszlo, B. J. Whittle, S. Moncada. 1993. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 110:1189.[Medline]
  37. Karupiah, G., J.-H. Chen, S. Mahalingam, C. F. Nathan, J. D. MacMicking. 1998. Rapid interferon {gamma}-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1541.[Abstract/Free Full Text]
  38. Doherty, T. M., A. Sher. 1997. Defects in cell-mediated immunity affect chronic, but not innate resistance to Mycobacterium avium infection. J. Immunol. 158:4822.[Abstract]
  39. Khan, I. A., J. D. Shwartzman, T. Masuura, L. H. Kasper. 1997. A dichotomous role for nitric oxide inhibition during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 94:13955.[Abstract/Free Full Text]
  40. Rajan, T. V., P. Porte, J. A. Yates, L. Keefer, L. D. Schultz. 1996. Role of nitric oxide in host defense against an extracellular metazoan parasite, Brugia malayi. Infect. Immun. 64:3351.[Abstract]
  41. Oswald, I. P., T. A. Wynn, A. Sher, S. L. James. 1994. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108:11.[Medline]
  42. Taylor, M. J., H. F. Cross, A. A. Mohammed, A. J. Trees, A. E. Bianco. 1996. Susceptibility of Brugia malayi and Onchocerca lienalis microfilariae to nitric oxide and hydrogen peroxide cell-free culture and from IFN{gamma}-activated macropahges. Parasitology 112:315.
  43. Tepperman, B. L., J. F. Brown, B. J. R. Whittle. 1993. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am. J. Physiol. 265:G214.[Abstract/Free Full Text]
  44. Bidri, M., S. Ktorza, I. Vouldoukis, L. Le Goff, P. Debre, J-J. Guillosson, M. Arock. 1997. Nitric oxide pathway is induced by Fc{epsilon}R1 and upregulated by stem cell factor in mouse mast cells. Eur. J. Immunol. 27:2907.[Medline]
  45. Kubes, P., M. Suzuki, D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88:4651.[Abstract/Free Full Text]
  46. Li, C. K. F., R. Seth, T. Gray, R. Bayston, Y. R. Mahida, D. Wakelin. 1998. Production of proinflammatory cytokines and inflammatory mediators in human intestinal epithelial cells after invasion by Trichinella spiralis. Infect. Immun. 66:2200.[Abstract/Free Full Text]
  47. Donaldson, L. E., E. Schmitt, J. F. Huntley, G. F. J. Newlands, R. K. Grencis. 1996. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int. Immunol. 8:559.[Abstract/Free Full Text]
  48. Faulkner, H., J.-C. Renauld, J. Van Snick, R. K. Grencis. 1998. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66:3832.[Abstract/Free Full Text]
  49. Galli, S. J., J. R. Gordon, B. K. Wershil. 1991. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 3:865.[Medline]
  50. Bissonnette, E. Y., C. M. Hogaboam, J. L. Wallace, A. D. Befus. 1991. Potentiation of tumor necrosis factor-{alpha}-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147:3060.[Abstract]
  51. James, S. L., A. W. Cheever, P. Caspar, T. A. Wynn. 1998. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect. Immun. 66:3510.[Abstract/Free Full Text]
  52. Chang, R.-H., M.-H. Lin Feng, W.-H. Liu, M.-Z. Lai. 1997. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90:364.[Medline]
  53. Lefer, D. J., R. Scalia, B. Campbell, T. Nossuli, R. Hayward, M. Salamon, J. Grayson, A. M. Lefer. 1997. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischaemia-reperfusion injury in rats. J. Clin. Invest. 99:684.[Medline]
  54. Artis, D., N. E. Humphreys, A. J. Bancroft, N. J. Rothwell, C. S. Potten, R. K. Grencis. 1999. Tumor necrosis factor {alpha} is a critical component of interleukin 13–mediated protective T helper cell type 2 responses during helminth infection. J. Exp. Med. 190:953.[Abstract/Free Full Text]
  55. Beckman, J. S., T. W. Beckman, J. Chen, Marshall P. A., Freeman B. A.. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620.[Abstract/Free Full Text]
  56. Mourad, F. H., L. J. O’Donnell, E. A. Andre, C. P. Bearcroft, R. A. Owen, M. L. Clark, M. J. Farthing. 1996. L-Arginine, nitric oxide, and intestinal secretion: studies in rat jejunum in vivo. Gut 39:539.[Abstract/Free Full Text]
  57. Branka, J. E., G. Vallette, A. Jarry, C. L. Laboisse. 1997. Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway. Biochem. J. 323:521.
  58. Guy-Grand, D., J. P. DiSanto, P. Henchoz, M. Malassis-Seris, P. Vassalli. 1998. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-{gamma}, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol. 28:730.[Medline]



This article has been cited by other articles:


Home page
 Infect. Immun.Home page
H. Tezuka, S. Imai, S. Tsukidate, and K. Fujita
A Dirofilaria immitis Polyprotein Up-Regulates Nitric Oxide Production
Infect. Immun., September 1, 2002; 70(9): 5283 - 5286.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. B. Nickdel, F. Roberts, F. Brombacher, J. Alexander, and C. W. Roberts
Counter-Protective Role for Interleukin-5 during Acute Toxoplasma gondii Infection
Infect. Immun., February 1, 2001; 69(2): 1044 - 1052.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lawrence, C. E.
Right arrow Articles by Kennedy, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawrence, C. E.
Right arrow Articles by Kennedy, M. W.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS